Cystatin C is a new marker for left ventricular hypertrophy in patients with chronic kidney disease
Aim. To estimate the diagnostic value of serum cystatin C in the development of left ventricular hypertrophy (LVH) in patients with chronic kidney disease (CKD). Subjects and methods. The investigation enrolled 86 patients (53% men, 47% women; mean age, 45±13 years) with nondiabetic CKD. According t...
المؤلفون الرئيسيون: | , , , |
---|---|
التنسيق: | مقال |
اللغة: | Russian |
منشور في: |
"Consilium Medicum" Publishing house
2015-06-01
|
سلاسل: | Терапевтический архив |
الموضوعات: | |
الوصول للمادة أونلاين: | https://ter-arkhiv.ru/0040-3660/article/view/31741 |